Investigating the effects of changing heart and diabetes medications during post-hospital care
Epidemiology and Long-Term Effect of Cardiometabolic Medication Substitution during Post-acute Care
['FUNDING_R03'] · HEBREW REHABILITATION CENTER FOR AGED · NIH-10974389
This study looks at how older adults' heart and diabetes medications change when they move from hospitals to nursing homes, focusing on whether cheaper substitutes are as effective, so we can better understand how these changes affect their health over time.
Quick facts
| Phase | ['FUNDING_R03'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | HEBREW REHABILITATION CENTER FOR AGED (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10974389 on ClinicalTrials.gov |
What this research studies
This research examines how older adults experience changes in their heart and diabetes medications when moving from hospitals to skilled nursing facilities. It focuses on the common issue of medication discrepancies, particularly substitutions of high-cost, effective medications with cheaper alternatives that may not work as well. By analyzing medication records from various skilled nursing facilities, the study aims to understand the impact of these substitutions on patients' long-term health outcomes. The goal is to identify patterns and consequences of medication changes that occur during this critical transition period.
Who could benefit from this research
Good fit: Ideal candidates for this research include older adults transitioning from acute hospital care to skilled nursing facilities who are on cardiometabolic medications.
Not a fit: Patients who are not transitioning from hospital to skilled nursing care or those not on cardiometabolic medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved medication management for older adults, enhancing their health outcomes after hospital stays.
How similar studies have performed: Previous research has indicated that medication discrepancies during transitions of care can significantly affect patient outcomes, suggesting that this investigation could build on established findings.
Where this research is happening
BOSTON, UNITED STATES
- HEBREW REHABILITATION CENTER FOR AGED — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PARK, CHAN MI — HEBREW REHABILITATION CENTER FOR AGED
- Study coordinator: PARK, CHAN MI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Adult-Onset Diabetes Mellitus